Stockscreener 앱 받기
104.84
2.91%
-3.14
시간 외 거래:
105.70
0.86
+0.82%
전일 마감가:
$107.98
열려 있는:
$107
하루 거래량:
1.07M
Relative Volume:
1.24
시가총액:
$7.13B
수익:
$1.50B
순이익/손실:
$427.61M
주가수익비율:
17.44
EPS:
6.01
순현금흐름:
$423.98M
1주 성능:
+0.85%
1개월 성능:
+15.31%
6개월 성능:
+14.99%
1년 성능:
+38.84%
1일 변동 폭
$104.40
$108.91
1주일 범위
$101.53
$108.91
52주 변동 폭
$74.28
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
명칭
Lantheus Holdings Inc
전화
978 671-8001
주소
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
LNTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
104.84 | 7.13B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
149.87 | 69.33B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.17 | 48.09B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.67 | 46.34B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.12 | 18.47B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
295.02 | 13.57B | 2.76B | 1.11B | 898.10M | 22.77 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Goldman | Buy |
| 2024-09-03 | 개시 | Redburn Atlantic | Buy |
| 2024-07-10 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-12-18 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | 개시 | TD Cowen | Outperform |
| 2023-09-29 | 개시 | William Blair | Outperform |
| 2023-03-08 | 개시 | JMP Securities | Mkt Outperform |
| 2022-11-30 | 개시 | SVB Leerink | Outperform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-05-09 | 개시 | B. Riley Securities | Buy |
| 2022-04-13 | 개시 | Truist | Buy |
| 2021-02-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-29 | 재개 | Jefferies | Buy |
| 2019-08-16 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-09-23 | 재개 | Credit Suisse | Neutral |
| 2016-02-24 | 재확인 | RBC Capital Mkts | Outperform |
| 2015-12-11 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | 개시 | Credit Suisse | Outperform |
| 2015-07-20 | 개시 | Jefferies | Buy |
| 2015-07-20 | 개시 | RBC Capital Mkts | Outperform |
| 2015-07-20 | 개시 | Robert W. Baird | Outperform |
| 2015-07-20 | 개시 | Wells Fargo | Outperform |
모두보기
Lantheus Holdings Inc 주식(LNTH)의 최신 뉴스
Lantheus to sell SPECT Business to SHINE Technologies - Seeking Alpha
Lantheus divests SPECT business to SHINE Technologies - Investing.com
SHINE Technologies Announces Plan to Acquire Lantheus' SPECT Division, Expanding Market Reach and Leadership in Nuclear Medicine - Yahoo Finance
Lantheus Earnings: What To Look For From LNTH - Yahoo Finance
Lantheus Holdings (NasdaqGM:LNTH) Advances Alzheimer's PET Diagnostic With Successful Trial Results - Yahoo Finance
Lantheus (LNTH) Advances Alzheimer's Imaging Agent MK-6240 - GuruFocus
Lantheus announces pivotal trial win for Alzheimer’s imaging agent - Seeking Alpha
Fund Update: BRIDGES INVESTMENT MANAGEMENT INC added 13,439 shares of LANTHEUS HOLDINGS ($LNTH) to their portfolio - Nasdaq
Lantheus Says Alzheimer's Disease Radiodiagnostic MK-6240 Meets Primary Endpoints in Two Trials - marketscreener.com
Lantheus (LNTH) Achieves Key Milestones with MK-6240 Radiodiagno - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool By Investing.com - Investing.com India
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 M - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool - Investing.com Australia
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies - The Manila Times
Lantheus Holdings, Inc. Announces Positive Results for MK-6240, a Potential Alzheimer's Disease Diagnostic Tool - Nasdaq
Lantheus Announces Alzheimer's Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints In Two Pivotal Studies - marketscreener.com
Lantheus's Revolutionary Alzheimer's Brain Scan Hits Major Milestone, FDA Filing Next - Stock Titan
Lantheus Holdings, Inc. (LNTH): Among Stocks with Consistent Growth to Buy Now - MSN
Breaking News: FDA Approves a Highly Sensitive Prostate Cancer Imaging Agent - PCF | Prostate Cancer Foundation
Lantheus Holdings Inc (LNTH) Shares Gap Down to $100.08 on Apr 2 - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
11 Stocks with Consistent Growth to Buy Now - Insider Monkey
Lantheus to Host First Quarter 2025 Earnings Conference Call and - GuruFocus
Lantheus Holdings, Inc. Announces Conference Call to Discuss Q1 2025 Financial Results - Nasdaq
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Lantheus Q1 2025 Earnings Call: How to Join the May 7 Investor Presentation - Stock Titan
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Could Be 44% Below Their Intrinsic Value Estimate - simplywall.st
In tough environment, Lantheus has cash and plans to use it - The Business Journals
(LNTH) Proactive Strategies - news.stocktradersdaily.com
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights By Investing.com - Investing.com India
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - The Globe and Mail
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights - Investing.com India
LNTH Quantitative Stock Analysis - Nasdaq
3 Leading Stocks Estimated To Be Up To 45.9% Below Intrinsic Value - Yahoo Finance
Lantheus Closes Evergreen Theragnostics Acquisition - MarketScreener
Lantheus Completes Acquisition of Evergreen Theragnostics - TipRanks
Lantheus completes acquisition of Evergreen Theragnostics - TipRanks
Lantheus bolsters radiopharmaceutical portfolio with acquisition - Investing.com
Major Radiopharmaceutical Deal: Lantheus Acquires Evergreen, Gains Revenue-Generating Assets - Stock Titan
How To Trade (LNTH) - news.stocktradersdaily.com
Lobbying Update: $420,000 of LANTHEUS HOLDINGS INC. lobbying was just disclosed - Nasdaq
Q4 Earnings Review: Medical Devices & SuppliesImaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC) - The Globe and Mail
CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment - Yahoo Finance
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH) - Yahoo Finance
Lantheus Holdings: One Blockbuster, Evolving Pipeline (NASDAQ:LNTH) - Seeking Alpha
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock? - simplywall.st
How to Take Advantage of moves in (LNTH) - Stock Traders Daily
Insider Sell: Marshall Robert J. Jr. Sells 10,000 Shares of Lant - GuruFocus.com
Lantheus price target lowered to $122 from $127 at B. Riley - TipRanks
B. Riley Cuts Price Target on Lantheus Holdings to $122 From $127, Keeps Buy Rating - Marketscreener.com
Lantheus Holdings CFO Marshall sells $1.01 million in stock By Investing.com - Investing.com Australia
Lantheus Holdings Inc (LNTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
8.36%
자본화:
|
볼륨(24시간):